Skip to main content

enVVeno Medical Corp

NVNO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001661053

In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding enVVeno Medical Corp changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of NVNO: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders32126−5
Shares3.64M43.7K3.29M−310.8K (−8.6%)
Value$19.8M$237.5K$17.3M−$2.32M (−11.8%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held enVVeno Medical Corp at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to NVNO in Q2 2024
InstitutionSharesValue% of portfolio
Arthur M. Cohen & Associates, LLC14,000$73.5K0.01%
Simplex Trading, LLC667$3.00K0.00%
Bank of America Corp99$5200.00%

Sold out (8)

Institutions that held enVVeno Medical Corp at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of NVNO in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Velan Capital Investment Management LP172,235$937.0K
Marshall Wace, LLP40,120$218.3K
Janney Montgomery Scott LLC34,140$186.0K
Jane Street Group, LLC25,313$137.7K
Squarepoint Ops LLC22,402$121.9K
Quadrature Capital Ltd18,872$103.2K
HRT Financial LP13,873$75.0K
Acadian Asset Management LLC6,825$37.0K

Not filed for Q2 2024 yet (1)

Institutions that held enVVeno Medical Corp at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding NVNO in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
RIA Advisory Group LLC43,666$237.5K